Top Tweets for #ASC024
We're excited to be joined by Jens Huober, Isabell Witzel, and Konstantin Dedes for an insightful discussion on the latest therapeutic advances for #BreastCancer following #ASC024.
⏰ July 2nd at 6PM CEST
Join the discussion for free - it's CME-certified ⬇️
Cancer du sein : Décryptage par @LeFigaro_Sante des 3 études cliniques prometteuses présentées par l'@institut_curie au congrès de l'#ASC024 qui pourraient améliorer considérablement la prise en charge des #cancersdusein dits triple négatifs ↘️
https://t.co/uC6H7FCm3a
Dr. Wang PhIII TNTCRT high-risk StII-III #LARC RCT 1:1 TNT w/long-course RT vs CRT (47-49% T4a) ➡️ pCR rate 27.51 vs 9.84%, absolute benefit 9% in DFS w/TNT over CRT and similar locoregional failure, but no OS difference
#ASCO24 @OncoAlert @manjuggm
Nikki Williams @nciccr_gmb @NCIResearchCtr presented data from a study of Prospective #PSMA🩻 Monitoring #BCR #ProstateCancer #ASC024
https://t.co/0RQSZEhdoI
Pts are willing to defer therapy after a discussion of known risks/benefits
Accrual continues
https://t.co/xCEFXIDiRK
#ASC024 Plenary
Ph III ADRIATIC trial of consolidation Durva +/- Treme post cCRT for LS SCLC:
⏺️mOS 55.9 vs 33.4mo (HR 0.73, p=0.01)
⏺️mPFS 16.6 vs 9.2mo
Had a fantastic experience presenting my findings on real world outcomes of Pembrolizumab vs Cetuximab based therapy in R/M HNSCC at #ASC024 Grateful for the valuable feedback and discussions with experts in the field. Special thanks to @GilbertodeCas13 for his valuable feedback
This morning @ASCO, Massey fellow @HamediZahra, M.D., presented findings comparing the efficacy of multiple treatment regimens for head and neck tumors.
"Real-world data from U.S. patients confirms superiority of pembrolizumab-based therapy over cetuximab." #ASCO24
PATRICIA Cohort C wonderfully presented by Eva Ciruelos
Palbo+ H+ ET vs TPC in PAM50 LumA/B HR+/HER2+ ABC, at least 1 prior line tx
n=73
2 median prior lines
PFS improved 7.5 vs 9.1 mo, HR 0.52, p=0.03
@OncoAlert @_SOLTI #ASC024 #bcsm
🎯 This slide of millions: what does the sequencing of HR+ HER2- metastatic breast cancer look like after #ASC024 ?
Every day more options⏩
Remembering the possibility of re-exposing to CDK4/6i 👇🏻
@OncoAlert
Important study presented today at #ASC024 in the HR+ HER2- postMONARCH metastatic breast cancer oral session: Abemaciclib + Fulvestrant after progression to CDK4/6i+ endocrine therapy.
@OncoAlert
Appreciated the balanced take and this study! This space will continue to be where the art of medicine and nuanced multidisplinary discussions are key. #lcsm #ASC024
Congrats to @IyengarPuneeth and @NRGonc for LU002. Important study showing SBRT does not synergize with IO in mNSCLC. #ASCO2024, #MedIQASCO2024
🏃♀️Did someone say #ExerciseOncology?
🏃♀️This poster by Dr. @PauloBergerot on the "Effect of a 12-week remote exercising program on #QOL & symptoms of older pts with cancer in Brazil will blow your minds!
🏃♀️Got questions? Stop by Hall A, PB #494; June 1st, 9:00AM-12:00PM #ASC024
🚨Anyone looking for a poster on #YoungLungCancer at #ASC024⁉️
🚨Head over to Hall A, #PB 233, where Dr. @NarjustFlorezMD will present updates on "Young Lung Cancer: Psychosocial Needs Assessment"💯
🚨You don't want to miss it!
🗓️June 3rd, 2024; 1:30-4:30PM
#ASC024 @ASCO 👩⚕️👩🏾⚕️👩🏻⚕️👩🏿⚕️
Stellar line up of events in the Women Networking Center!
Check the events, and join in on the conversation
@AnaVManana @fumikochino @DeepaRangachari
@HemOncWomenDocs @ASCOPres @jrgralow @OncoAlert
Join us Saturday 6/1 at 1:00 PM at #ASCO24 Women’s Networking Center for a panel discussion on “Strategic Visibility: Elevating Visibility Through Personal Branding”
Honored to share my experience & learn from @fumikochino @DeepaRangachari @jackiebrown_MD
Don’t miss the Women’s Networking Lounge events 🔥🔥
#WomenInMedicine #WomenInOncology
@HemOncWomenDocs @ASCO @UCSFCancer @WomeninOnc
#Covid19 accelerated the use of decentralized trial (DCT) elements in cancer trials. Our study is the first to evaluate DCT elements used in cancer trials submitted to @FDAOncology & led to marketing approval.
Check out our @ASCO abstract - https://t.co/84iJnpRD58
#ASC024
The PACIFIC-2 trial by @astrazeneca has generated confusion, surprise, and even seemed to strike a nerve 😬 among Lung Cancer Specialists. Follow the powerful discussions of Key Opinion Leaders in Thoracic Surgery, Medical Oncology, and Radiation Oncology. #lcsm #asc024
👉https://t.co/8OZWEJrWLb
🚨 #ASCO24 abstract titles are out!
🥁 Exciting #PlenarySession, specially for #LCSM community!
1⃣ ESOPEC, periop chemo (FLOT) vs. neoadj chemoRT (CROSS) for esophageal adeno #ESOCSM
2⃣ NADINA, neoadj ipilimumab + nivolumab vs. adj nivolumab for stage III melanoma #MELSM
3⃣ Telehealth vs. in-person early #PallOnc for pts with advanced #LungCancer
4⃣ LAURA, osimertinib post-chemoRT in unresectable EGFRm NSCLC
5⃣ ADRIATIC, consolidation durvalumab for LS-SCLC
@UCSFCancer @ASCO
Last Seen Hashtags on Sotwe
bijibiratî
Seen from United States
ReputationTourMNL
Seen from United States
เย็ดเมียชาวบ้าน
Seen from Thailand
bugurusalsa
Seen from Indonesia
momson(*****)********+filter:native_video
Seen from Netherlands
BblCommunity
Seen from Germany
momson()filter:native_video
Seen from United States
diyarbakırtravesti
Seen from Turkey
WereBasic
nolimit Teenage*() +filter:native_video
Seen from Pakistan
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.4M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.9M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.1M followers
Taylor Swift
@taylorswift13
82M followers
Lady Gaga
@ladygaga
73.5M followers
Virat Kohli
@imvkohli
70.6M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.1M followers
Neymar Jr
@neymarjr
63.4M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61.2M followers
X
@x
60.8M followers